MeSH term
Frequency | Condition_Probility | Acute Disease | 10 | 0.0 |
Adult | 85 | 0.0 |
Comparative Study | 29 | 0.0 |
Humans | 280 | 0.0 |
Animals | 86 | 0.0 |
Immunohistochemistry | 33 | 0.0 |
Macrophage Migration-Inhibitory Factors/genetics/*immunology/metabolism | 2 | 100.0 |
Male | 106 | 0.0 |
Mice | 50 | 0.0 |
Mice, Inbred BALB C | 13 | 0.0 |
Mice, Inbred C57BL | 8 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 138 | 0.0 |
Time Factors | 16 | 0.0 |
Tumor Necrosis Factor-alpha/analysis | 3 | 0.0 |
Cell Division/drug effects | 3 | 0.0 |
Cells, Cultured | 40 | 0.0 |
Endometriosis/*metabolism | 2 | 6.0 |
Endothelium, Vascular/cytology | 2 | 0.0 |
Female | 103 | 0.0 |
Reference Values | 11 | 0.0 |
Retrospective Studies | 7 | 0.0 |
Disease Progression | 6 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 60 | 0.0 |
Models, Molecular | 6 | 0.0 |
Structure-Activity Relationship | 4 | 0.0 |
Child | 16 | 0.0 |
Child, Preschool | 8 | 0.0 |
Diagnosis, Differential | 5 | 0.0 |
Drug Eruptions/*diagnosis | 2 | 66.0 |
Infant | 6 | 0.0 |
Aged | 49 | 0.0 |
C-Reactive Protein/analysis | 2 | 0.0 |
Case-Control Studies | 13 | 0.0 |
Macrophage Migration-Inhibitory Factors/*blood | 17 | 94.0 |
Middle Aged | 73 | 0.0 |
Neoplasm Staging | 3 | 0.0 |
Predictive Value of Tests | 3 | 0.0 |
Prognosis | 11 | 0.0 |
3T3 Cells | 2 | 0.0 |
Cell Line | 11 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Hela Cells | 4 | 0.0 |
L Cells (Cell Line) | 2 | 0.0 |
Macrophages/*metabolism | 3 | 1.0 |
Protein Binding | 11 | 0.0 |
Staining and Labeling | 2 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Image Processing, Computer-Assisted | 4 | 1.0 |
Immunoenzyme Techniques | 7 | 0.0 |
Macrophage Migration-Inhibitory Factors/*metabolism | 8 | 88.0 |
Pain Measurement | 2 | 2.0 |
Enzyme-Linked Immunosorbent Assay | 22 | 0.0 |
Lipopolysaccharides/pharmacology | 2 | 0.0 |
Antibodies, Bacterial/*blood/immunology | 2 | 66.0 |
Chlamydia trachomatis/*immunology | 4 | 33.0 |
Chlamydophila pneumoniae/*immunology | 4 | 22.0 |
Fluorescent Antibody Technique | 8 | 0.0 |
Tumor Cells, Cultured | 10 | 0.0 |
Blotting, Western | 17 | 0.0 |
Interleukin-1/metabolism | 2 | 0.0 |
Macrophages/pathology | 2 | 1.0 |
Neoplasm Metastasis | 3 | 0.0 |
*Neovascularization, Pathologic | 2 | 0.0 |
Phenotype | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 14 | 0.0 |
Up-Regulation | 12 | 0.0 |
Inflammation Mediators/analysis | 2 | 8.0 |
Tumor Necrosis Factor-alpha/immunology | 2 | 1.0 |
Corticotropin/blood | 2 | 1.0 |
Hypothalamo-Hypophyseal System/*physiopathology | 2 | 3.0 |
Pituitary-Adrenal System/*physiopathology | 2 | 8.0 |
Shock, Septic/immunology | 3 | 30.0 |
Signal Transduction | 5 | 0.0 |
Fibrosis | 3 | 2.0 |
Inflammation/metabolism/pathology | 2 | 8.0 |
Macrophages/drug effects/metabolism | 2 | 4.0 |
Transcription, Genetic | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Macrophage Migration-Inhibitory Factors/analysis/*biosynthesis | 3 | 75.0 |
Prospective Studies | 4 | 0.0 |
RNA, Messenger/genetics | 6 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Interferon Type II/pharmacology | 3 | 0.0 |
Adolescent | 22 | 0.0 |
Concanavalin A/pharmacology | 7 | 3.0 |
Macrophage Migration-Inhibitory Factors/*biosynthesis/blood | 2 | 100.0 |
Statistics, Nonparametric | 5 | 0.0 |
T-Lymphocytes/*metabolism | 2 | 0.0 |
Osmolar Concentration | 5 | 0.0 |
Severity of Illness Index | 8 | 0.0 |
Pharyngitis/*microbiology | 2 | 100.0 |
Dose-Response Relationship, Drug | 9 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 6 | 0.0 |
Macrophage Migration-Inhibitory Factors/*antagonists & inhibitors | 2 | 50.0 |
Recombinant Proteins/metabolism | 5 | 0.0 |
Amino Acid Sequence | 14 | 0.0 |
Molecular Sequence Data | 29 | 0.0 |
Base Sequence | 10 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Chromosomes, Human, Pair 22/genetics | 2 | 2.0 |
Cloning, Molecular | 4 | 0.0 |
Exons | 2 | 0.0 |
Gene Expression | 8 | 0.0 |
Introns | 3 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
RNA, Messenger/analysis | 12 | 0.0 |
Rats | 14 | 0.0 |
Rats, Sprague-Dawley | 5 | 0.0 |
Aged, 80 and over | 14 | 0.0 |
Macrophage Migration-Inhibitory Factors/*biosynthesis | 12 | 60.0 |
Biological Markers | 2 | 0.0 |
Aqueous Humor/*chemistry | 2 | 28.0 |
Enzyme-Linked Immunosorbent Assay/methods | 5 | 1.0 |
Flow Cytometry | 3 | 0.0 |
Macrophage Migration-Inhibitory Factors/*analysis | 12 | 100.0 |
Vitreous Body/*chemistry | 2 | 13.0 |
Mice, Knockout | 6 | 0.0 |
Inflammation | 3 | 0.0 |
Receptors, Retinoic Acid/*analysis | 2 | 33.0 |
Hydrocortisone/blood | 2 | 0.0 |
Interferon Type II/blood | 2 | 1.0 |
Survival Rate | 2 | 0.0 |
Tumor Necrosis Factor-alpha/metabolism | 2 | 0.0 |
Macrophages/physiology | 2 | 2.0 |
Rabbits | 6 | 0.0 |
Tumor Necrosis Factor-alpha/*analysis | 2 | 0.0 |
*Kidney Transplantation | 2 | 0.0 |
Transplantation, Homologous | 2 | 0.0 |
Disease Models, Animal | 5 | 0.0 |
Macrophage Migration-Inhibitory Factors/*immunology | 8 | 88.0 |
Macrophages/immunology | 18 | 6.0 |
Monocytes/immunology | 3 | 0.0 |
Cytokines/*metabolism | 3 | 1.0 |
English Abstract | 15 | 0.0 |
Arthritis, Rheumatoid/*enzymology | 2 | 16.0 |
Recombinant Proteins | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/*analysis/blood | 4 | 100.0 |
Statistics | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/*urine | 2 | 100.0 |
Inflammation/immunology | 2 | 1.0 |
Antibodies, Bacterial/*analysis | 2 | 8.0 |
Cross Reactions | 4 | 0.0 |
Injections, Intravenous | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Cattle | 5 | 0.0 |
Recombinant Proteins/immunology | 2 | 0.0 |
Gene Expression/genetics | 2 | 0.0 |
Genotype | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/*genetics | 6 | 100.0 |
*Gene Expression Profiling | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/analysis | 7 | 87.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Chronic Disease | 6 | 0.0 |
*Cell Cycle Proteins | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/*physiology | 5 | 83.0 |
Precipitin Tests | 2 | 0.0 |
Antibodies, Monoclonal/*immunology | 2 | 0.0 |
Eosinophils/*immunology | 2 | 3.0 |
Matched-Pair Analysis | 2 | 2.0 |
Gonadorelin/agonists | 2 | 11.0 |
Hydrocortisone/*pharmacology | 2 | 5.0 |
Lipopolysaccharides | 3 | 2.0 |
Macrophage Migration-Inhibitory Factors/immunology/*metabolism | 4 | 100.0 |
In Situ Hybridization | 4 | 0.0 |
Macrophage Activation | 5 | 2.0 |
Macrophage Migration-Inhibitory Factors/*biosynthesis/genetics | 3 | 100.0 |
Diabetic Retinopathy/*metabolism | 2 | 8.0 |
Polymerase Chain Reaction | 12 | 0.0 |
Neoplasm Invasiveness | 3 | 0.0 |
Antibodies, Monoclonal | 3 | 0.0 |
Chromatography, Affinity | 4 | 0.0 |
Macrophage Migration-Inhibitory Factors/*analysis/immunology | 2 | 100.0 |
Biopsy | 3 | 0.0 |
Brain/metabolism | 2 | 0.0 |
Skin/cytology | 2 | 1.0 |
Thrombin/*pharmacology | 2 | 1.0 |
Macrophage Migration-Inhibitory Factors/*pharmacology | 4 | 50.0 |
Mutation | 5 | 0.0 |
Protein Denaturation | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/genetics/*metabolism | 2 | 100.0 |
Glucocorticoids/*physiology | 2 | 11.0 |
Inflammation/*physiopathology | 2 | 3.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Rats, Wistar | 3 | 0.0 |
Wound Healing/*physiology | 2 | 3.0 |
Lymphocyte Activation | 12 | 0.0 |
Macrophage Migration-Inhibitory Factors/*analysis/genetics | 2 | 100.0 |
Macrophages/metabolism | 3 | 0.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
Cell Division | 4 | 0.0 |
Drug Combinations | 2 | 0.0 |
Bacterial Proteins/immunology | 2 | 9.0 |
Prostatic Hyperplasia/*metabolism/pathology | 2 | 6.0 |
Pregnancy | 5 | 0.0 |
Antibodies, Bacterial/*blood | 2 | 4.0 |
Macrophage Migration-Inhibitory Factors/blood/*metabolism | 3 | 100.0 |
Binding Sites | 2 | 0.0 |
Crystallization | 2 | 0.0 |
Crystallography, X-Ray | 3 | 0.0 |
Macrophage Migration-Inhibitory Factors/*chemistry | 2 | 50.0 |
Protein Structure, Secondary | 2 | 0.0 |
*Sequence Homology, Amino Acid | 2 | 2.0 |
*Ultraviolet Rays | 2 | 0.0 |
Uveitis/*blood | 2 | 66.0 |
Cell Movement | 2 | 0.0 |
Macrophages/drug effects | 4 | 13.0 |
Chlamydia Infections/*immunology | 2 | 16.0 |
Mice, Inbred C3H | 2 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Phenylpyruvic Acids/metabolism | 2 | 100.0 |
Rats, Inbred Strains | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Protein Folding | 3 | 0.0 |
Temperature | 3 | 0.0 |
Neutrophils/immunology | 2 | 1.0 |
Protein Conformation | 6 | 0.0 |
Sequence Analysis | 3 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/analysis/*biosynthesis/genetics | 2 | 100.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Sulfhydryl Compounds/pharmacology | 2 | 11.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/pharmacology/*physiology | 3 | 75.0 |
Immunity, Cellular | 6 | 0.0 |
Peptide Mapping | 2 | 0.0 |
Clinical Trials | 2 | 0.0 |
Macrophages/*immunology | 11 | 4.0 |
*Protein Structure, Secondary | 2 | 1.0 |
Hypersensitivity, Delayed/immunology | 2 | 3.0 |
Guinea Pigs | 15 | 1.0 |
T-Lymphocytes/immunology/metabolism | 2 | 1.0 |
Cell Communication | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Molecular Structure | 2 | 0.0 |
Interleukin-2/biosynthesis | 3 | 0.0 |
Kinetics | 3 | 0.0 |
Lymphocyte Activation/*drug effects | 2 | 0.0 |
Spleen/immunology | 2 | 1.0 |
Multivariate Analysis | 2 | 0.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Syndrome | 3 | 0.0 |
Cell Differentiation | 5 | 0.0 |
RNA, Messenger/analysis/biosynthesis | 2 | 0.0 |
Rabbits/immunology | 3 | 3.0 |
Sequence Alignment | 3 | 0.0 |
Dexamethasone/pharmacology | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/biosynthesis/*physiology | 2 | 100.0 |
Recombinant Proteins/pharmacology | 7 | 0.0 |
Molecular Weight | 8 | 0.0 |
Solubility | 3 | 0.0 |
Immunoglobulin G/analysis | 2 | 0.0 |
Nitric Oxide/metabolism | 2 | 1.0 |
Mice, Nude | 2 | 0.0 |
T-Lymphocytes/metabolism | 2 | 0.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 2 | 0.0 |
Horses | 2 | 1.0 |
Immunoblotting | 2 | 0.0 |
Immunochemistry | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/*chemistry/metabolism | 2 | 100.0 |
Gene Expression/drug effects | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/*genetics/metabolism | 2 | 100.0 |
Microscopy, Electron | 2 | 0.0 |
Cell Cycle | 3 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Cell Membrane/drug effects | 2 | 5.0 |
Chelating Agents/pharmacology | 2 | 2.0 |
Detergents/pharmacology | 2 | 1.0 |
Estrogen Antagonists/*pharmacology | 2 | 2.0 |
Estrogen Receptor alpha/drug effects | 2 | 33.0 |
Estrogens/pharmacology | 2 | 2.0 |
Estrogens, Non-Steroidal/*pharmacology | 2 | 11.0 |
Fluorescent Dyes | 2 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Phytoestrogens/pharmacology | 2 | 28.0 |
Solvents/pharmacology | 2 | 8.0 |
Steroids/pharmacology | 2 | 5.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Xenopus laevis | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/*isolation & purification | 2 | 100.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
Caspases/metabolism | 2 | 0.0 |
Cytochromes c/metabolism | 2 | 3.0 |
Macrophage Migration-Inhibitory Factors/genetics/metabolism/*pharmacology | 2 | 100.0 |
*Cell Migration Inhibition | 11 | 28.0 |
Follow-Up Studies | 5 | 0.0 |
Acid Phosphatase/pharmacology | 2 | 100.0 |
Macrophages/*physiology | 2 | 2.0 |
Insulin Resistance | 2 | 1.0 |
Up-Regulation/physiology | 2 | 1.0 |
Drug Synergism | 3 | 0.0 |
MSH Release-Inhibiting Hormone/*pharmacology/therapeutic use | 2 | 100.0 |
Phosphorylation | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 3 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
In Vitro | 11 | 0.0 |
Cell Migration Inhibition | 15 | 14.0 |
Immunity, Cellular/drug effects | 2 | 3.0 |
Tunicamycin/pharmacology | 2 | 2.0 |
Chromatography, Gel | 6 | 0.0 |
Isoelectric Focusing | 4 | 0.0 |
Phytohemagglutinins/pharmacology | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
*Ascites | 2 | 100.0 |
Ovarian Neoplasms/*analysis | 2 | 40.0 |
Radioimmunoassay | 3 | 0.0 |
Drug Therapy, Combination | 2 | 0.0 |
Retinoblastoma Protein/metabolism | 2 | 0.0 |
Antigen-Antibody Complex | 2 | 1.0 |
Freezing | 2 | 2.0 |
Monocytes/*immunology | 2 | 0.0 |
Survival Analysis | 3 | 0.0 |
Transfer Factor/*therapeutic use | 2 | 5.0 |
Lymphokines/*biosynthesis | 6 | 2.0 |
Immunity, Cellular/*drug effects | 2 | 4.0 |
Infant, Newborn | 3 | 0.0 |
Lymphocytes/drug effects/immunology | 2 | 6.0 |
Macrophage Migration-Inhibitory Factors/biosynthesis | 5 | 45.0 |
Colony-Stimulating Factors/biosynthesis | 2 | 28.0 |
Concanavalin A/*pharmacology | 2 | 7.0 |
Interferon Type II/biosynthesis | 2 | 0.0 |
*Lymphocyte Activation | 5 | 0.0 |
Lymphocytes/immunology | 8 | 2.0 |
Oxygen/pharmacology | 2 | 5.0 |
Spleen/cytology | 3 | 1.0 |
Antigens, Surface | 2 | 3.0 |
Macrophages/cytology/immunology/*physiology | 2 | 66.0 |
Cytotoxicity, Immunologic | 3 | 0.0 |
Macrophage-Activating Factors | 3 | 9.0 |
Lymphocytes/*immunology | 6 | 1.0 |
Species Specificity | 2 | 0.0 |
Drug Tolerance | 2 | 1.0 |
*Cytotoxicity, Immunologic | 2 | 0.0 |
Drug Hypersensitivity/*immunology | 3 | 42.0 |
Leukocytes/immunology | 2 | 1.0 |
Apoptosis | 2 | 0.0 |
Hepatitis/*immunology | 2 | 28.0 |
Immunoglobulins/analysis | 2 | 0.0 |
*Immunity, Cellular | 7 | 5.0 |
Macrophage Migration-Inhibitory Factors | 2 | 50.0 |
Tuberculin | 3 | 30.0 |
Skin Tests | 5 | 2.0 |
Antibodies/*analysis | 2 | 1.0 |
Antigen-Antibody Reactions | 2 | 0.0 |
Hemagglutination Tests | 2 | 2.0 |
Heat | 2 | 0.0 |
Lectins/pharmacology | 3 | 8.0 |
Immunosuppression | 2 | 1.0 |
Multiple Sclerosis/*immunology | 2 | 1.0 |
Myelin Basic Proteins/*immunology | 2 | 1.0 |
Peripheral Nervous System Diseases/immunology | 2 | 25.0 |
Leukocyte Count | 2 | 0.0 |
Guinea Pigs/immunology | 2 | 13.0 |
Corticotropin/*blood | 2 | 3.0 |
MSH/*blood | 2 | 100.0 |
Transfection | 3 | 0.0 |
Sarcoidosis/*immunology | 3 | 13.0 |
Hypersensitivity, Delayed | 4 | 6.0 |
Skin Diseases/*immunology | 2 | 9.0 |
Antigens | 3 | 3.0 |
Macrophage Migration-Inhibitory Factors/blood/*genetics | 2 | 100.0 |
